ClinicalTrials.Veeva

Menu

EXplanted LIver and Ex-vivo Pancreatic Specimen Evaluation by 7 TESLA MRI (EXLIPSE)

U

University of Pisa

Status

Unknown

Conditions

Liver Cirrhosis
Hepatocellular Carcinoma
Liver Steatosis
Magnetic Resonance Imaging
Pancreatic Cancer

Treatments

Diagnostic Test: 7T Magnetic Resonance Imaging

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Aim of this study is to evaluate the correlation between the characteristics detected by the 7T MRI equipment and the histological composition of native explanted livers (group A), liver graft excluded for donation (group B) and surgical specimens of primary pancreatic tumour, which underwent pancreaticoduodenectomy (group C).

Enrollment

30 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

GROUP A of Native Liver

Inclusion Criteria:

  • informed consent
  • full possession of one's faculties
  • patients who are going to undergo liver transplantation, independently from previous therapy or from the primary disease they are affected by.

Exclusion Criteria:

  • patients affected by polycystic liver disease
  • excluded from liver transplantation.

GROUP B of Excluded Grafts

Inclusion Criteria:

  • liver grafts with histologically proven macrovescic steatosis, not fit for transplantation

Exclusion Criteria:

  • liver grafts histologically proven macrovescic steatosis fit for transplantation
  • liver grafts not fit for transplantation due to causes other than steatosis

GROUP C of Focal Pancreatic Lesion

Inclusion Criteria:

  • informed consent
  • full possession of one's faculties
  • pancreatic lesion assessed by CT examination and histologically proved, which are candidates for pancreaticoduodenectomy or total pancreatectomy

Exclusion Criteria:

  • excluded from surgery due to the severity of their condition.

Trial design

Primary purpose

Basic Science

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

30 participants in 1 patient group

EX-VIVO SPECIMENS
Experimental group
Description:
Three groups of ex-vivo surgical specimen: Group A: native livers in transplant recipients Group B: liver grafts excluded for donation Group C: primary pancreatic cancer
Treatment:
Diagnostic Test: 7T Magnetic Resonance Imaging

Trial contacts and locations

1

Loading...

Central trial contact

Laura Crocetti, MD,PhD; Rosa Cervelli, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems